Analyst: Gambro buy a good use of Baxter's cash

Published: December 6, 2012 6:00 am ET

Related to this story

Topics Medical, Mergers & Acquisitions

DEERFIELD, ILL. (Dec. 6, 12:40 p.m. ET) — Buying Lund, Sweden-based Gambro for $4 billion, including assumed debt, is a good way for Deerfield-based Baxter International Inc. to use its offshore cash, analyst Danielle Antalffy, with Boston-based health investment bank Leerink Swann LLC, said in a research note on Dec. 4, after the deal was announced.

Baxter’s offshore cash accounts for more than two-thirds of its $3 billion in cash, Antalffy noted. With $1.6 billion in annual revenue, Gambro is a leading manufacturer of equipment and products for hemodialysis, or HD, one form of the transfusion treatment for patients with kidney disease. Baxter, with annual revenue of $13.8 billion, was a pioneer in that field but changed its focus to peritoneal dialysis, or PD, another transfusion therapy, which patients can give themselves at home. HD is usually performed in a clinic or hospital.

Gambro acquisition not without challenges

Some “yellow flags” could complicate the Gambro acquisition, which should be a positive transaction for Baxter, according to a research note issued by Chicago-based investment firm William Blair & Co. LLC. “Gambro has reported relatively flat growth over the past several years,” analyst Ben Andrew wrote, “and we believe it will take at least a year after closing before growth reaccelerates.”

Another cause for concern is the recent weak quarter by the world’s top dialysis product manufacturer, Bad Hamburg, Germany-based Fresenius Medical Care AG, which blamed poor sales on the economy. Overall, the deal should strengthen Baxter’s position in a growing kidney treatment market, bumping its renal revenue to 25 percent of sales, from 20 percent, and generating an estimated $300 million in annual cost synergies by 2017, he said. The yellow flags “are not impossible to overcome, and we believe Baxter will be able to do so over time as they cross-fertilize products from both companies across their combined geographic footprint,” the Blair report said.

Expansion into Europe is a question

Moody’s Investors Service Inc. said Dec. 4 that it placed Baxter’s longer-term A3 debt rating on review for a possible downgrade. “The size of the transaction and company’s plan that this will be funded with $3 billion of additional debt creates concern,” according to a news release. “Furthermore, we believe a significant portion of Gambro’s sales are derived from Europe, which is currently undergoing greater contraction due to austerity measures.” Standard & Poor’s Financial Services LLC warned of a possible downgrade last week.


Comments

Analyst: Gambro buy a good use of Baxter's cash

Published: December 6, 2012 6:00 am ET

Post Your Comments


Back to story


More stories

Image

Inteplast expands in corrugated sheet with Coroplast deal

August 21, 2014 5:28 pm ET

Packaging major Inteplast Group has acquired its main competitor in corrugated plastic sheet, Coroplast Inc. Inteplast gets corrugated sheet plants...    More

Image

NanoHolding, Applied Nanotech merge to form PEN Inc.

August 21, 2014 4:44 pm ET

Nanotechnology firms NanoHolding Inc. and Applied Nanotech Holdings Inc. are merging to create PEN Inc., a publicly held firm whose product mix will...    More

Image

Report predicts growth for flexible packaging

August 21, 2014 12:34 pm ET

Flexible packaging in the United States grew last year and is expected to continue to grow this year, according to a new report by the Flexible...    More

Image

German injection molders Metz-Werke and Inotech to collaborate

August 21, 2014 11:47 am ET

German injection molding companies Metz-Werke GmbH & Co. KG and Inotech Kunststofftechnik GmbH have announced that they have joined forces to bring...    More

Image

German firms combine hybrid part expertise

August 21, 2014 11:18 am ET

L. Possehl & Co.'s acquisition of TPS Technical Plastic Systems GmbH will bring together companies which specialize in the manufacture of hybrid plast...    More

Market Reports

Thermoformed Packaging 2014 Market Review & Outlook North America

This in-depth report analyzes economic and market trends, legislative/regulatory activity impacting supply and demand, business opportunities and threats, materials pricing, manufacturing technology, as well as growth strategies being implemented by thermoformed packaging companies.

Learn more

Pipe, Profile & Tubing Extrusion in North America 2014

U.S. demand for extruded plastics is expected to grow by 3 percent in 2014, with PVC remaining the largest segment.

Plastic pipe will post the strongest gains through 2018, continuing to take market share from competing materials in a range of markets.

Our latest market report provides in-depth analysis of current trends and their financial impact on the pipe, profile and tubing extrusion industry in North America.

Learn more

2014 Injection Molding Industry Report

GROWTH, OPPORTUNITY IN SIGHT FOR INJECTION MOLDERS IN 2014

In the wake of the economic turbulence earlier in this decade, molders today find themselves in much better shape. Molders are gaining a competitive advantage by investing in people, equipment and seeking inroads into new markets on a global scale.

Growth in the injection molding industry is going to be driven by low financing costs and a continued move to reshore some business.

Learn more

Upcoming Plastics News Events

September 10, 2014 - September 12, 2014Plastics Caps & Closures 2014

January 14, 2015 - January 14, 2015Plastics in Automotive

February 4, 2015 - February 6, 2015Plastics News Executive Forum 2015

More Events